A Follow-up Study to Evaluate Lipids as Cost-Effective Markers in HIV-Infected Patients on Antiretroviral Therapy

A Follow-up Study to Evaluate Lipids as Cost-Effective Markers in HIV-Infected Patients on Antiretroviral Therapy

Background: Human immunodeficiency virus (HIV) infection per se and antiretroviral therapy (ART) both are associated with dyslipidemias, one of the important risk factors in the development of premature atherosclerosis and coronary artery disease. Certain classes of highly active antiretroviral ther...

Full description

Bibliographic Details
Main Authors: Amrita Parmar, Tapan Kumar Saha, Babu Lal Somani, Pratibha Misra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Medical Journal of Dr. D.Y. Patil Vidyapeeth
Subjects:
cardiovascular diseases
highly active antiretroviral therapy
human immunodeficiency virus-infected patients
lipid profile
Online Access:http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2021;volume=14;issue=2;spage=162;epage=165;aulast=Parmar

Internet

http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2021;volume=14;issue=2;spage=162;epage=165;aulast=Parmar

Similar Items